Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouseA La Cava, B Balasa, A Good, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytesB Balasa, J D Davies, J Lee, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic miceB Balasa, T Krahl, G Patstone, et al.The Journal of Experimental Medicine|August 4, 1997
Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in miceB Balasa, C Deng, J Lee, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 moleculesB Balasa, K Van Gunst, N Jung, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetesB Balasa, A La Cava, K Van Gunst, et al.Proceedings of the National Academy of Sciences of the United States of America|June 8, 2001
Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouseF D Shi, M Flodstrom, B Balasa, et al.Clinical Immunology (Orlando, Fla.)|April 25, 2001
Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protectionB Balasa, B O Boehm, A Fortnagel, et al.Pageof 2